期刊文献+

载阿霉素的叶酸-壳聚糖微球的制备及其体外缓释性研究 被引量:3

Preparation and characterization of doxorubicin loated folate-chitosan microspheres as a sustained-release drugs carrier
下载PDF
导出
摘要 为了提高阿霉素对肿瘤组织的靶向性,增强其抗肿瘤活性,延长其在人体内的作用时间。以壳聚糖为药物载体、叶酸为肿瘤靶向配体,在水相中采用离子交联法一步合成载阿霉素的叶酸-壳聚糖微球。利用动态光散射、透射电镜对微球的结构、平均粒径及粒径分布、形态特征、对药物的包封率及载药量、体外释放等特点进行了初步研究。结果表明:所制得的微球平均粒径为32.85μm。扫描电镜下观察其形态圆整,大小均匀,无粘连。对阿霉素包封率为(89.8±0.1)%,载药量为(20.5±0.1)%。在人工胃液pH=1.2及人工小肠液pH=6.8条件下具有很好的缓控释作用且无突释现象。 In order to enhance the tumor-targeting and anticancer activity of doxorubicin (DOX) and extend the in vivo effect of time, chitosan (CTS) was used as drug vector and folate (FA) as tumor targeting ligand. The doxorubicin-loaded microspheres composed of FA - conjugated CTS were prepared via an one - step ionic crosslinking approach in aqueous solution. The morphological characteristics of microspheres were examined using a transmission electron microscope (TEM). The average diameter of microspheres and size distribution were determined by dynamic light scattering. The drug encapsulation efficiency( EE), loading capacity(LC) and in vitro release characteris- tics were determined using ultraviolet spectrophotometer. It indicated that the mierospheres display spherical appear- ance with uniform size of 32. 85 μm. Optimized preparation parameters lead to the successful preparation of DOX-loaded folate-conjugated chitosan microspheres characterized with encapsulation efficiency and loading capacity of (89. 8±0. 1 ) % and (20. 5 ±0. 1 ) %, respectively. About 90% of DOX was released from microspheres in 8 h in artificial small intestinal fluid. The results indicate the microspheres have good delayed release effect without burst-releasing phenomena.
作者 邢志华
出处 《黑龙江大学自然科学学报》 CAS 北大核心 2012年第4期511-514,共4页 Journal of Natural Science of Heilongjiang University
基金 哈尔滨市科技创新人才研究专项资金资助项目(2010RFQXS077)
关键词 叶酸 壳聚糖 微球 阿霉素 离子交联 olate chitosan microspheres doxombicin ionic crosslinking
  • 相关文献

参考文献7

  • 1ASHKENAZI A, DIXIT V M. Death receptors: signaling and modulation [ J]. Science, 1998, 281 (5381) : 1305 - 1308. 被引量:1
  • 2LEAMON C P. Folate-mediated targeting from diagonostics to drug and gene delivery" [ J]. DDT, 2001,6 ( 1 ) :44 -51. 被引量:1
  • 3YANG T, CHOU C, LI C. Preparation, water solubility and rheologieal property of the N - alkylated mono or disaccharide chitosan derivatives [J]. FoodReslnt, 2002, 35(8): 707 -713. 被引量:1
  • 4TAN Y L, LIU C G. Preparation and characterization of self- assemblied nanoparticles based on folic acid modified carboxymethly chitosan [ J ]. Mater. Sci : Mater Med,2011,22 : 1213 - 1220. 被引量:1
  • 5邢志华,方桂珍.离子交联法制备叶酸-壳聚糖微球工艺研究[J].黑龙江医药,2011,24(6):915-917. 被引量:7
  • 6LU Y J. Folate - mediated delivery of macromolecular anticancer therapeutic agents[ J ]. Adv Drug Deliv Rev,2002 ,54 :675 - 693. 被引量:1
  • 7杨琰,赵颖,张凤兰,黄颢,张团英,张红菱.叶酸偶联率对叶酸-壳聚糖纳米粒靶向抗瘤性的影响[J].肿瘤防治研究,2011,38(7):740-744. 被引量:4

二级参考文献19

  • 1蒋建伟,张洹.叶酸受体介导的药物靶向投递系统研究进展[J].国外医学(临床生物化学与检验学分册),2004,25(4):345-347. 被引量:8
  • 2张程亮,孙纳.壳聚糖用于抗肿瘤治疗的研究进展[J].中国药房,2005,16(7):549-551. 被引量:17
  • 3Basarkar A, Singh J. Nanoparticulate syslems for polynuclc otide delivery[J]. Int J Nanomedicine, 2007, 2(3):353-360. 被引量:1
  • 4Hasegawa M, Yagi K, lwakawa S, et al. Chitosan induces ap optosis via caspase-3 activati on in bladder tumor cells[J ]. jtm J Cancer Res, 2001, 92(4):459-466. 被引量:1
  • 5Dashwood RH. Use of Iransgenic and mutant animal models in the study of heterocyclic amine-induced mutagenesis and car cinogens[J]. J Biochem Mol Biol, 2003, 36( 1 ):35-42. 被引量:1
  • 6Siegel BA, Dehdashti F, Mutch DG, et al. Evaluation of In DTPA-Folate as a receptor targeteddiagnoslic agent for owri an cancer: initial clinical resulls[J]. J Nucl Med, 2003, 44 ( 5 ) : 710-707. 被引量:1
  • 7Felt O, Carrel A, Baehni P, et al. Chitoan as tear subs titute: a wetting agent endowed with antimicrohial efficacy [J]. J Ocul Pharmacol Ther, 2000, 16(3):261-2711. 被引量:1
  • 8Liang HF, Chen CT, Chen SC, et al, Paclitaxel-loaded poly (gamma-glutamic acid) poly (lactide) nanoparticles as a targe ted drug delivery system for the treatment of liver Caneer[J]. Biomaterials, 20{}6, 27(9):2051-2059. 被引量:1
  • 9Weitman SD, Lark P,H, Coney I.R, et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and lis- sues[J].. ancer Res, 1992, 52(12) :3390- 3401. 被引量:1
  • 10Stevens PJ, kido M, l.ee RJ, A folate reeeptcr target lipid nanopartieles formulation for it lipophilie paclitaxel prodrug[J]. I'harmRes, 2004, 21(12):2153 -2157. 被引量:1

共引文献8

同被引文献26

  • 1汤佳明,赵修华,祖元刚.盐酸表阿霉素纳米靶向制剂的缓释效应[J].中国组织工程研究,2013,17(21):3846-3853. 被引量:8
  • 2韩涛,李富荣,周汉新.阿霉素纳米微球靶向药物制剂的研究进展[J].中国药物与临床,2004,4(10):737-740. 被引量:5
  • 3黄园,袁芳,张志荣.肿瘤靶向给药系统的研究进展[J].华西药学杂志,2006,21(6):566-569. 被引量:4
  • 4陈英杰,许向阳,周建平.乳酸-羟基乙酸共聚物微球的研究进展[J].中国药科大学学报,2007,38(2):186-189. 被引量:11
  • 5Gabler F, Frauenschuh S, Ringe J, et al. Emulsion-based synthesis of PLGA-microspheres for the in vitro expansion of porcine chondrocytes [ J ]. Biomol Eng, 2007,24 ( 5 ) : 515-520. 被引量:1
  • 6Tahara K, Kato Y, Yamamoto H, et al. Intracellular drug delivery using polysorbate 80-modifiedpoly (D, L-lactide-co- glycolide) nanospheres to glioblastoma cells [J]. J Microencapsul, 2011,28(1) :29-36. 被引量:1
  • 7Zou L, Song X, Yi T, et al. Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer [J]. Cancer Gene Ther, 2013,20(4) : 242-250. 被引量:1
  • 8ChavanpatilM D, Patil Y, Panyam J. Susceptibility of nanoparticle-encapsu lated paclitaxel to P-glycoprotein- mediated drug efflux [Jl. Int J Ph arm, 2006,320(1-2) : 150-156. 被引量:1
  • 9Barraud L, Merle P, Soma E, et al.Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma ceils in vitro and in vivo [J]. J Hepatol, 2005 , 42(5) : 736-743. 被引量:1
  • 10吴金民;赵昌峻.实用肿瘤治疗手册[M]{H}杭州:浙江科学技术出版社,20001-3. 被引量:1

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部